New pill aims to silence hepatitis b virus in patients with stubborn Low-Level infection
NCT ID NCT06644417
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called TQA3605 in 122 adults with chronic hepatitis B who still had low levels of virus despite standard treatment. Participants took either TQA3605 or a placebo alongside their usual antiviral pills for 24 weeks. The goal was to see if adding TQA3605 could push the virus below detectable levels and improve safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TQA3605 tablets (a core protein regulator)
- What this could lead to
- If successful, this could offer a new treatment option to help people with chronic hepatitis B achieve undetectable virus levels, potentially reducing liver damage and disease progression.
- What could go wrong
- This is an early-phase (Phase II) trial with only 122 participants, so results may not apply to everyone. The drug may not work better than current therapy, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HBV INFECTION WITH LOW-LEVEL VIREMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Ditan Hospital Capital Medical University
Beijing, Beijing Municipality, 100015, China
-
Beijing Youan Hospital, Capital Medical Universitybeijing Institute of Hepatology
Beijing, Beijing Municipality, 100054, China
-
Guizhou Provincial People's Hospital
Guiyang, Guizhou, 550002, China
-
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, 210000, China
-
Lishui People's Hospital
Lishui, Zhejiang, 323000, China
-
Meng Chao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, 350001, China
-
Peking University Shenzhen Hospital
Shenzhen, Guangdong, 518036, China
-
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200000, China
-
Shandong Public Health Clinical Center
Jinan, Shandong, 250102, China
-
Shanghai Tongren Hospital
Shanghai, Shanghai Municipality, 200336, China
-
The Fifth People's Hospital of Suzhou
Suzhou, Jiangsu, 215131, China
-
The First Affiliated Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, 310006, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330000, China
-
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi’an, Shanxi, 710000, China
-
The Second XIANGYA Hospital Of Central South University
Changsha, Hunan, 410008, China
-
The sixth people's Hospital Of Shenyang
Shenyang, Liaoning, 110001, China
-
Yueyang Central Hospital
Yueyang, Hunan, 414000, China
-
Zhengzhou No.6 peoples Hospital
Zhengzhou, Henan, 450000, China
-
Zunyi Medical University Affiliated Hospital
Zunyi, Guizhou, 563000, China